Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04175249
Other study ID # PIMETA
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 26, 2019
Est. completion date May 30, 2020

Study information

Verified date July 2022
Source Charite University, Berlin, Germany
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

High salt intake is a major risk factor for cardiovascular events, including stroke, heart disease and kidney failure. Pizza is a popular salty food. In this exploratory pilot study, the effects of a pizza meal challenge on immunometabolism in healthy subjects will be tested.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date May 30, 2020
Est. primary completion date April 30, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - Healthy men and women Exclusion Criteria: - Severe, manifest illnesses in need of treatment - Pathological lab results - Inability to understand significance and scope of the study

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Pizza meal challenge
Vegetarian pizza containing 10 grams of salt

Locations

Country Name City State
Germany Experimental & Clinical Research Center Berlin

Sponsors (1)

Lead Sponsor Collaborator
Charite University, Berlin, Germany

Country where clinical trial is conducted

Germany, 

References & Publications (1)

Geisberger S, Bartolomaeus H, Neubert P, Willebrand R, Zasada C, Bartolomaeus T, McParland V, Swinnen D, Geuzens A, Maifeld A, Krampert L, Vogl M, Mähler A, Wilck N, Markó L, Tilic E, Forslund SK, Binger KJ, Stegbauer J, Dechend R, Kleinewietfeld M, Jants — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Oxygen consumption rate of immune cells OCR (pmol oxygen/min/1000 cells) measured by Seahorse 3 hours after the pizza compared to baseline
Secondary Oxygen consumption rate of immune cells OCR (pmol oxygen/min/1000 cells) measured by Seahorse 3 and 8 hours after the pizza adjusted for plasma sodium concentration compared to baseline
Secondary Plasma sodium Plasma sodium concentration (mmol/l) 3 and 8 hours after the pizza compared to baseline
Secondary Mitochondrial membrane potential of immune cells Mitochondrial membrane potential (Mean Fluorescence Intensity of TMRE) measured by flow cytometry 3 and 8 hours after the pizza compared to baseline
Secondary Extracellular acidification rate of immune cells ECAR (mpH/min/1000 cells) measured by Seahorse 3 and 8 hours after the pizza compared to baseline
Secondary Interleukin 17 release after monocyte and T cell co-culture IL-17 concentration (pg/ml) measured by ELISA Cell isolation at baseline and 3 hours after the pizza followed by 72 hours of co-culture
Secondary Interferon-gamma release after monocyte and T cell co-culture INF-g concentration (pg/ml) measured by ELISA Cell isolation at baseline and 3 hours after the pizza followed by 72 hours of co-culture
Secondary Adenosine triphophate production of immune cells Percent change of luminescence (%) measured by Luminescence Assay 3 and 8 hours after the pizza compared to baseline
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1

External Links